Failure of Goserelin Ovarian Ablation in Premenopausal Women with Breast Cancer: Two Case Reports

By Jimenez-Gordo A.M.   de las Heras B.   Zamora P.   Espinosa E.   Gonzalez-Baron M.  

Gynecologic Oncology, Vol. 76, Iss. 1, 2000-01 ,pp. : 126-127

Elsevier

Access to resources Recommend Favorite

Monthly versus 3-monthly goserelin acetate treatment in pre-menopausal patients with estrogen receptor-positive early breast cancer

By Masuda Norikazu   Iwata Hiraji   Rai Yoshiaki   Anan Keisei   Takeuchi Toru   Kohno Norio   Takei Hiroyuki   Yanagita Yasuhiro   Noguchi Shinzaburo  

Breast Cancer Research and Treatment, Vol. 126, Iss. 2, 2011-04 ,pp. : 443-451

Springer Publishing Company

Access to resources Recommend Favorite

An individual patient-based meta-analysis of tamoxifen versus ovarian ablation as first line endocrine therapy for premenopausal women with metastatic breast cancer

By Crump M.  

Breast Cancer Research and Treatment, Vol. 44, Iss. 3, 1997-07 ,pp. : 201-210

Springer Publishing Company

Access to resources Recommend Favorite

Avascular Necrosis Following Extensive Chemotherapy and Dexamethasone Treatment in a Patient with Advanced Ovarian Cancer: Case Report and Review of the Literature

By Gogas H.   Fennelly D.  

Gynecologic Oncology, Vol. 63, Iss. 3, 1996-12 ,pp. : 379-381

Academic Press

Access to resources Recommend Favorite

Tamoxifen as Systemic Treatment of Advanced Breast Cancer during Pregnancy-Case Report and Literature Review

By Isaacs R.J.   Hunter W.   Clark K.  

Gynecologic Oncology, Vol. 80, Iss. 3, 2001-03 ,pp. : 405-408

Elsevier

Access to resources Recommend Favorite